메뉴 건너뛰기




Volumn 10, Issue 1, 2017, Pages

Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure with Reduced Ejection Fraction: A Network Meta-Analysis

Author keywords

drug combinations; drug therapy; heart failure; mortality; network meta analysis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CANRENONE; CARVEDILOL; ENALAPRIL; EPLERENONE; FOSINOPRIL; LOSARTAN; METOPROLOL; MINERALOCORTICOID ANTAGONIST; NEBIVOLOL; SPIRAPRIL;

EID: 85010070469     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.116.003529     Document Type: Article
Times cited : (188)

References (87)
  • 3
    • 40949086056 scopus 로고    scopus 로고
    • Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study)
    • Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008;101:1016-1022. doi: 10.1016/j.amjcard.2007.11.061.
    • (2008) Am J Cardiol , vol.101 , pp. 1016-1022
    • Loehr, L.R.1    Rosamond, W.D.2    Chang, P.P.3    Folsom, A.R.4    Chambless, L.E.5
  • 4
    • 75549091095 scopus 로고    scopus 로고
    • Heart failure burden and therapy
    • Zannad F, Agrinier N, Alla F. Heart failure burden and therapy. Europace. 2009;11(suppl 5):v1-v9. doi: 10.1093/europace/eup304.
    • (2009) Europace , vol.11 , pp. v1-v9
    • Zannad, F.1    Agrinier, N.2    Alla, F.3
  • 6
    • 84969871823 scopus 로고    scopus 로고
    • 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
    • Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016;134:e282-e293. doi: 10.1161/CIR.0000000000000435.
    • (2016) Circulation , vol.134 , pp. e282-e293
    • Yancy, C.W.1    Jessup, M.2    Bozkurt, B.3    Butler, J.4    Casey, D.E.5    Colvin, M.M.6    Drazner, M.H.7    Filippatos, G.8    Fonarow, G.C.9    Givertz, M.M.10    Hollenberg, S.M.11    Lindenfeld, J.12    Masoudi, F.A.13    McBride, P.E.14    Peterson, P.N.15    Stevenson, L.W.16    Westlake, C.17
  • 8
    • 84879818084 scopus 로고    scopus 로고
    • Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
    • Jansen JP, Naci H. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med. 2013;11:159. doi: 10.1186/1741-7015-11-159.
    • (2013) BMC Med , vol.11 , pp. 159
    • Jansen, J.P.1    Naci, H.2
  • 9
    • 69949092149 scopus 로고    scopus 로고
    • Addressing between- study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation
    • Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ. Addressing between- study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med. 2009;28:1861-1881. doi: 10.1002/sim.3594.
    • (2009) Stat Med , vol.28 , pp. 1861-1881
    • Cooper, N.J.1    Sutton, A.J.2    Morris, D.3    Ades, A.E.4    Welton, N.J.5
  • 10
    • 84879740382 scopus 로고    scopus 로고
    • Evidence synthesis for decision making 2: A generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials
    • Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33:607-617. doi: 10.1177/0272989X12458724.
    • (2013) Med Decis Making , vol.33 , pp. 607-617
    • Dias, S.1    Sutton, A.J.2    Ades, A.E.3    Welton, N.J.4
  • 11
    • 79959925787 scopus 로고    scopus 로고
    • Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
    • Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011;14:417-428. doi: 10.1016/j.jval.2011.04.002.
    • (2011) Value Health , vol.14 , pp. 417-428
    • Jansen, J.P.1    Fleurence, R.2    Devine, B.3    Itzler, R.4    Barrett, A.5    Hawkins, N.6    Lee, K.7    Boersma, C.8    Annemans, L.9    Cappelleri, J.C.10
  • 12
    • 84925548115 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006-1012. doi: 10.1016/j. jclinepi.2009.06.005.
    • (2009) J Clin Epidemiol , vol.62 , pp. 1006-1012
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4
  • 13
    • 70249117194 scopus 로고    scopus 로고
    • Layerthorpe, York, UK: Centre for Reviews and Dissemination, University of York
    • CRD's Guidance for Undertaking Reviews in Health Care. Layerthorpe, York, UK: Centre for Reviews and Dissemination, University of York; 2008.
    • (2008) CRD's Guidance for Undertaking Reviews in Health Care
  • 14
    • 84903725920 scopus 로고    scopus 로고
    • A process for assessing the feasibility of a network meta-analysis: A case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer
    • Cope S, Zhang J, Saletan S, Smiechowski B, Jansen JP, Schmid P. A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer. BMC Med. 2014;12:93. doi: 10.1186/1741-7015-12-93.
    • (2014) BMC Med , vol.12 , pp. 93
    • Cope, S.1    Zhang, J.2    Saletan, S.3    Smiechowski, B.4    Jansen, J.P.5    Schmid, P.6
  • 15
    • 26944454062 scopus 로고    scopus 로고
    • Simultaneous comparison of multiple treatments: Combining direct and indirect evidence
    • Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331:897-900. doi: 10.1136/bmj.331.7521.897.
    • (2005) BMJ , vol.331 , pp. 897-900
    • Caldwell, D.M.1    Ades, A.E.2    Higgins, J.P.3
  • 16
    • 52649100566 scopus 로고    scopus 로고
    • Bayesian meta-analysis of multiple treatment comparisons: An introduction to mixed treatment comparisons
    • Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008;11:956-964. doi: 10.1111/j.1524-4733.2008.00347.x.
    • (2008) Value Health , vol.11 , pp. 956-964
    • Jansen, J.P.1    Crawford, B.2    Bergman, G.3    Stam, W.4
  • 17
    • 5044221416 scopus 로고    scopus 로고
    • Combination of direct and indirect evidence in mixed treatment comparisons
    • Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-3124. doi: 10.1002/ sim.1875.
    • (2004) Stat Med , vol.23 , pp. 3105-3124
    • Lu, G.1    Ades, A.E.2
  • 20
    • 70449411807 scopus 로고    scopus 로고
    • The BUGS project: Evolution, critique and future directions
    • Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution, critique and future directions. Stat Med. 2009;28:3049-3067. doi: 10.1002/sim.3680.
    • (2009) Stat Med , vol.28 , pp. 3049-3067
    • Lunn, D.1    Spiegelhalter, D.2    Thomas, A.3    Best, N.4
  • 21
    • 0028886293 scopus 로고
    • Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure
    • Widimský J, Kremer HJ, Jerie P, Uhlír O. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure. Eur J Clin Pharmacol. 1995;49:95-102.
    • (1995) Eur J Clin Pharmacol , vol.49 , pp. 95-102
    • Widimský, J.1    Kremer, H.J.2    Jerie, P.3    Uhlír, O.4
  • 22
    • 0023266532 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). the CONSENSUS Trial Study Group
    • Swedberg K. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-1435.
    • (1987) N Engl J Med , vol.316 , pp. 1429-1435
    • Swedberg, K.1
  • 23
    • 20644461232 scopus 로고
    • Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group
    • Erhardt L, MacLean A, Ilgenfritz J, Gelperin K, Blumenthal M. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group. Eur Heart J. 1995;16:1892-1899.
    • (1995) Eur Heart J , vol.16 , pp. 1892-1899
    • Erhardt, L.1    MacLean, A.2    Ilgenfritz, J.3    Gelperin, K.4    Blumenthal, M.5
  • 24
    • 0027195253 scopus 로고
    • Long-term survival in the Munich Mild Heart Failure Trial (MHFT)
    • Kleber FX, Niemöller L. Long-term survival in the Munich Mild Heart Failure Trial (MHFT). Am J Cardiol. 1993;71:1237-1239.
    • (1993) Am J Cardiol , vol.71 , pp. 1237-1239
    • Kleber, F.X.1    Niemöller, L.2
  • 25
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. the SOLVD Investigators
    • Yusuf S. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med. 1992;327:685-691.
    • (1992) N Engl J Med , vol.327 , pp. 685-691
    • Yusuf, S.1
  • 26
    • 0025913812 scopus 로고
    • The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
    • Yusuf S; The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302. doi: 10.1056/ NEJM199108013250501.
    • (1991) N Engl J Med , vol.325 , pp. 293-302
    • Yusuf, S.1
  • 28
    • 0028927869 scopus 로고
    • Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group
    • Brown EJ Jr, Chew PH, MacLean A, Gelperin K, Ilgenfritz JP, Blumenthal M. Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group. Am J Cardiol. 1995;75:596-600.
    • (1995) Am J Cardiol , vol.75 , pp. 596-600
    • Brown, E.J.1    Chew, P.H.2    MacLean, A.3    Gelperin, K.4    Ilgenfritz, J.P.5    Blumenthal, M.6
  • 30
    • 0026725794 scopus 로고
    • Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. the Benazepril Heart Failure Study Group
    • Colfer HT, Ribner HS, Gradman A, Hughes CV, Kapoor A, Laidlaw JC. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group. Am J Cardiol. 1992;70:354-358.
    • (1992) Am J Cardiol , vol.70 , pp. 354-358
    • Colfer, H.T.1    Ribner, H.S.2    Gradman, A.3    Hughes, C.V.4    Kapoor, A.5    Laidlaw, J.C.6
  • 31
    • 0024294162 scopus 로고
    • Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. the Captopril-Digoxin Multicenter Research Group
    • Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. JAMA. 1988;259:539-544.
    • (1988) JAMA , vol.259 , pp. 539-544
  • 32
    • 0024504450 scopus 로고
    • Comparison of lisinopril versus placebo for congestive heart failure
    • Lewis GR. Comparison of lisinopril versus placebo for congestive heart failure. Am J Cardiol. 1989;63:12D-16D.
    • (1989) Am J Cardiol , vol.63 , pp. 12D-16D
    • Lewis, G.R.1
  • 33
    • 0032911302 scopus 로고    scopus 로고
    • Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure
    • Shettigar U, Hare T, Gelperin K, Ilgenfritz JP, Deitchman D, Blumenthal M. Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure. Congest Heart Fail. 1999;5:27-34.
    • (1999) Congest Heart Fail , vol.5 , pp. 27-34
    • Shettigar, U.1    Hare, T.2    Gelperin, K.3    Ilgenfritz, J.P.4    Deitchman, D.5    Blumenthal, M.6
  • 36
    • 0032727627 scopus 로고    scopus 로고
    • Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators
    • Riegger GA, Bouzo H, Petr P, Münz J, Spacek R, Pethig H, von Behren V, George M, Arens H. Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators. Circulation. 1999;100:2224-2230.
    • (1999) Circulation , vol.100 , pp. 2224-2230
    • Riegger, G.A.1    Bouzo, H.2    Petr, P.3    Münz, J.4    Spacek, R.5    Pethig, H.6    Von Behren, V.7    George, M.8    Arens, H.9
  • 40
    • 0035131633 scopus 로고    scopus 로고
    • Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) Investigators. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. the Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) investigators
    • discussion 139
    • Dunselman PH; Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) Investigators. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) investigators. Int J Cardiol. 2001;77:131-138; discussion 139.
    • (2001) Int J Cardiol , vol.77 , pp. 131-138
    • Dunselman, P.H.1
  • 41
    • 0029102699 scopus 로고
    • Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
    • Dickstein K, Chang P, Willenheimer R, Haunsø S, Remes J, Hall C, Kjekshus J. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol. 1995;26:438-445.
    • (1995) J Am Coll Cardiol , vol.26 , pp. 438-445
    • Dickstein, K.1    Chang, P.2    Willenheimer, R.3    Haunsø, S.4    Remes, J.5    Hall, C.6    Kjekshus, J.7
  • 42
    • 0030881016 scopus 로고    scopus 로고
    • Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. the Losartan Pilot Exercise Study Investigators
    • Lang RM, Elkayam U, Yellen LG, Krauss D, McKelvie RS, Vaughan DE, Ney DE, Makris L, Chang PI. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators. J Am Coll Cardiol. 1997;30:983-991.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 983-991
    • Lang, R.M.1    Elkayam, U.2    Yellen, L.G.3    Krauss, D.4    McKelvie, R.S.5    Vaughan, D.E.6    Ney, D.E.7    Makris, L.8    Chang, P.I.9
  • 43
    • 0041909380 scopus 로고    scopus 로고
    • CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting- enzyme inhibitors: The CHARM-Alternative trial
    • Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting- enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003;362:772-776. doi: 10.1016/S0140-6736(03)14284-5.
    • (2003) Lancet , vol.362 , pp. 772-776
    • Granger, C.B.1    McMurray, J.J.2    Yusuf, S.3    Held, P.4    Michelson, E.L.5    Olofsson, B.6    Ostergren, J.7    Pfeffer, M.A.8    Swedberg, K.9
  • 44
    • 0036773950 scopus 로고    scopus 로고
    • Heart Failure Valsartan Exercise Capacity Evaluation Study Group. Safety and efficacy of valsartan versus enalapril in heart failure patients
    • Willenheimer R, Helmers C, Pantev E, Rydberg E, Löfdahl P, Gordon A; Heart Failure Valsartan Exercise Capacity Evaluation Study Group. Safety and efficacy of valsartan versus enalapril in heart failure patients. Int J Cardiol. 2002;85:261-270.
    • (2002) Int J Cardiol , vol.85 , pp. 261-270
    • Willenheimer, R.1    Helmers, C.2    Pantev, E.3    Rydberg, E.4    Löfdahl, P.5    Gordon, A.6
  • 45
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. doi: 10.1056/ NEJM199909023411001.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 46
    • 51349155508 scopus 로고    scopus 로고
    • Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III trial
    • Dobre D, van Veldhuisen DJ, Goulder MA, Krum H, Willenheimer R. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III trial. Cardiovasc Drugs Ther. 2008;22:399-405. doi: 10.1007/s10557-008-6116-9.
    • (2008) Cardiovasc Drugs Ther , vol.22 , pp. 399-405
    • Dobre, D.1    Van Veldhuisen, D.J.2    Goulder, M.A.3    Krum, H.4    Willenheimer, R.5
  • 48
    • 0035818884 scopus 로고    scopus 로고
    • Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    • Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-1675. doi: 10.1056/ NEJMoa010713.
    • (2001) N Engl J Med , vol.345 , pp. 1667-1675
    • Cohn, J.N.1    Tognoni, G.2
  • 49
    • 0033514910 scopus 로고    scopus 로고
    • Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
    • Hamroff G, Katz SD, Mancini D, Blaufarb I, Bijou R, Patel R, Jondeau G, Olivari MT, Thomas S, Le Jemtel TH. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation. 1999;99:990-992.
    • (1999) Circulation , vol.99 , pp. 990-992
    • Hamroff, G.1    Katz, S.D.2    Mancini, D.3    Blaufarb, I.4    Bijou, R.5    Patel, R.6    Jondeau, G.7    Olivari, M.T.8    Thomas, S.9    Le Jemtel, T.H.10
  • 50
    • 0035978801 scopus 로고    scopus 로고
    • A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
    • Eichhorn EJ. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
    • (2001) N Engl J Med , vol.344 , pp. 1659-1667
    • Eichhorn, E.J.1
  • 51
    • 0028092116 scopus 로고
    • A randomized trial of beta-blockade in heart failure. the Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees
    • Lachat P. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation. 1994;90:1765-1773.
    • (1994) Circulation , vol.90 , pp. 1765-1773
    • Lachat, P.1
  • 52
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
    • Lechat P. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
    • Lechat, P.1
  • 53
    • 0034660225 scopus 로고    scopus 로고
    • Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. the CELICARD Group
    • Witchitz S, Cohen-Solal A, Dartois N, Weisslinger N, Juste K, Darmon JY. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group. Am J Cardiol. 2000;85:1467-1471.
    • (2000) Am J Cardiol , vol.85 , pp. 1467-1471
    • Witchitz, S.1    Cohen-Solal, A.2    Dartois, N.3    Weisslinger, N.4    Juste, K.5    Darmon, J.Y.6
  • 54
    • 0037433183 scopus 로고    scopus 로고
    • Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: Results from the COPERNICUS Study
    • Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA. 2003;289:712-718.
    • (2003) JAMA , vol.289 , pp. 712-718
    • Krum, H.1    Roecker, E.B.2    Mohacsi, P.3    Rouleau, J.L.4    Tendera, M.5    Coats, A.J.6    Katus, H.A.7    Fowler, M.B.8    Packer, M.9
  • 55
    • 19544370840 scopus 로고    scopus 로고
    • Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: Results of the ENECA study
    • Edes I, Gasior Z, Wita K. Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study. Eur J Heart Fail. 2005;7:631-639. doi: 10.1016/j.ejheart.2004.10.015.
    • (2005) Eur J Heart Fail , vol.7 , pp. 631-639
    • Edes, I.1    Gasior, Z.2    Wita, K.3
  • 56
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • Hjalmarson A. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
    • (1999) Lancet , vol.353 , pp. 2001-2007
    • Hjalmarson, A.1
  • 61
    • 2942527236 scopus 로고    scopus 로고
    • Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure
    • Cohen Solal A, Jondeau G, Beauvais F, Berdeaux A. Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure. Eur J Heart Fail. 2004;6:463-466. doi: 10.1016/j.ejheart.2003.12.007.
    • (2004) Eur J Heart Fail , vol.6 , pp. 463-466
    • Cohen Solal, A.1    Jondeau, G.2    Beauvais, F.3    Berdeaux, A.4
  • 64
    • 0009107171 scopus 로고    scopus 로고
    • Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure
    • de Milliano PA, de Groot AC, Tijssen JG, van Eck-Smit BL, Van Zwieten PA, Lie KI. Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure. Am Heart J. 2002;144:E3.
    • (2002) Am Heart J , vol.144 , pp. E3
    • De Milliano, P.A.1    De Groot, A.C.2    Tijssen, J.G.3    Van Eck-Smit, B.L.4    Van Zwieten, P.A.5    Lie, K.I.6
  • 65
    • 18744425643 scopus 로고    scopus 로고
    • Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: Analysis with magnetic resonance myocardial tagging
    • Dubach P, Myers J, Bonetti P, Schertler T, Froelicher V, Wagner D, Scheidegger M, Stuber M, Luchinger R, Schwitter J, Hess O. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging. Am Heart J. 2002;143:676-683.
    • (2002) Am Heart J , vol.143 , pp. 676-683
    • Dubach, P.1    Myers, J.2    Bonetti, P.3    Schertler, T.4    Froelicher, V.5    Wagner, D.6    Scheidegger, M.7    Stuber, M.8    Luchinger, R.9    Schwitter, J.10    Hess, O.11
  • 67
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
    • Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355. doi: 10.1056/ NEJM199605233342101.
    • (1996) N Engl J Med , vol.334 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3    Colucci, W.S.4    Fowler, M.B.5    Gilbert, E.M.6    Shusterman, N.H.7
  • 70
    • 0034534141 scopus 로고    scopus 로고
    • Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril
    • Sturm B, Pacher R, Strametz-Juranek J, Berger R, Frey B, Stanek B. Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril. Eur J Heart Fail. 2000;2:407-412.
    • (2000) Eur J Heart Fail , vol.2 , pp. 407-412
    • Sturm, B.1    Pacher, R.2    Strametz-Juranek, J.3    Berger, R.4    Frey, B.5    Stanek, B.6
  • 71
    • 0141882923 scopus 로고    scopus 로고
    • Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure
    • McKelvie RS, Rouleau JL, White M, Afzal R, Young JB, Maggioni AP, Held P, Yusuf S. Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. Eur Heart J. 2003;24:1727-1734.
    • (2003) Eur Heart J , vol.24 , pp. 1727-1734
    • McKelvie, R.S.1    Rouleau, J.L.2    White, M.3    Afzal, R.4    Young, J.B.5    Maggioni, A.P.6    Held, P.7    Yusuf, S.8
  • 72
    • 0034142256 scopus 로고    scopus 로고
    • Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: The randomized evaluation of strategies for left ventricular dysfunction pilot study
    • White M. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation. 2000;101:378-384.
    • (2000) Circulation , vol.101 , pp. 378-384
    • White, M.1
  • 73
    • 0041408235 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting- enzyme inhibitors: The CHARM-Added trial
    • McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting- enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767-771. doi: 10.1016/S0140-6736(03)14283-3.
    • (2003) Lancet , vol.362 , pp. 767-771
    • McMurray, J.J.1    Ostergren, J.2    Swedberg, K.3    Granger, C.B.4    Held, P.5    Michelson, E.L.6    Olofsson, B.7    Yusuf, S.8    Pfeffer, M.A.9
  • 76
    • 0037125404 scopus 로고    scopus 로고
    • Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure
    • Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Marino P, Zardini P. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol. 2002;40:304-310.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 304-310
    • Cicoira, M.1    Zanolla, L.2    Rossi, A.3    Golia, G.4    Franceschini, L.5    Brighetti, G.6    Marino, P.7    Zardini, P.8
  • 78
    • 85026341952 scopus 로고    scopus 로고
    • The importance of treatment classifications that account for concomitant treatments in the context of a network meta-analysis comparing pharmacological treatments for chronic heart failure
    • Burnett H, Cope S, Vieira MC, Sagkriotis A, Senni M, Deschaseaux C. The importance of treatment classifications that account for concomitant treatments in the context of a network meta-analysis comparing pharmacological treatments for chronic heart failure. Value Health. 2014;17:A327. doi: 10.1016/j.jval.2014.08.595.
    • (2014) Value Health , vol.17 , pp. A327
    • Burnett, H.1    Cope, S.2    Vieira, M.C.3    Sagkriotis, A.4    Senni, M.5    Deschaseaux, C.6
  • 79
    • 0035799381 scopus 로고    scopus 로고
    • Beta-blockers in congestive heart failure. A Bayesian meta-analysis
    • Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 2001;134:550-560.
    • (2001) Ann Intern Med , vol.134 , pp. 550-560
    • Brophy, J.M.1    Joseph, L.2    Rouleau, J.L.3
  • 81
    • 84876052291 scopus 로고    scopus 로고
    • Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: A systematic review and meta-analysis
    • Hu LJ, Chen YQ, Deng SB, Du JL, She Q. Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis. Br J Clin Pharmacol. 2013;75:1202-1212. doi: 10.1111/bcp.12012.
    • (2013) Br J Clin Pharmacol , vol.75 , pp. 1202-1212
    • Hu, L.J.1    Chen, Y.Q.2    Deng, S.B.3    Du, J.L.4    She, Q.5
  • 82
    • 0037028607 scopus 로고    scopus 로고
    • Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials
    • Jong P, Demers C, McKelvie RS, Liu PP. Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2002;39:463-470.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 463-470
    • Jong, P.1    Demers, C.2    McKelvie, R.S.3    Liu, P.P.4
  • 83
    • 77956322695 scopus 로고    scopus 로고
    • Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure
    • Kuenzli A, Bucher HC, Anand I, Arutiunov G, Kum LC, McKelvie R, Afzal R, White M, Nordmann AJ. Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure. PLoS One. 2010;5:e9946. doi: 10.1371/journal.pone.0009946.
    • (2010) PLoS One , vol.5
    • Kuenzli, A.1    Bucher, H.C.2    Anand, I.3    Arutiunov, G.4    Kum, L.C.5    McKelvie, R.6    Afzal, R.7    White, M.8    Nordmann, A.J.9
  • 84
    • 84989872584 scopus 로고    scopus 로고
    • Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: A meta-analysis
    • Solomon SD, Claggett B, McMurray JJ, Hernandez AF, Fonarow GC. Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis. Eur J Heart Fail. 2016;18:1238-1243. doi: 10.1002/ejhf.603.
    • (2016) Eur J Heart Fail , vol.18 , pp. 1238-1243
    • Solomon, S.D.1    Claggett, B.2    McMurray, J.J.3    Hernandez, A.F.4    Fonarow, G.C.5
  • 85
    • 84955465558 scopus 로고    scopus 로고
    • Renin-angiotensinaldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis
    • Xie W, Zheng F, Song X, Zhong B, Yan L. Renin-angiotensinaldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: network meta-analysis. Int J Cardiol. 2016;205:65-71. doi: 10.1016/j.ijcard.2015.12.010.
    • (2016) Int J Cardiol , vol.205 , pp. 65-71
    • Xie, W.1    Zheng, F.2    Song, X.3    Zhong, B.4    Yan, L.5
  • 87
    • 79955660223 scopus 로고    scopus 로고
    • Network meta-analysis of survival data with fractional polynomials
    • Jansen JP. Network meta-analysis of survival data with fractional polynomials. BMC Med Res Methodol. 2011;11:61. doi: 10.1186/ 1471-2288-11-61.
    • (2011) BMC Med Res Methodol , vol.11 , pp. 61
    • Jansen, J.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.